Arihant Capital Markets Ltd
ARIHANTCAPArihant Capital Markets Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved −21.4% in a year while annual EPS moved −49.1% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a downtrend (28 weeks in) while the P/BV sits at the 55th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +61.5% year on year, with the the net margin at 26.9%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Arihant Capital Markets Ltd trades at ₹78.3, in a downtrend and 28 weeks into that stage. That is +0.4% against its own 200-day average. It sits at 30% of a 52-week range of ₹62 to ₹116. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 4 straight weeks.
Today the stock is in a downtrend — week 28 of stage 4, confirmed. At ₹78.3 it trades +0.4% versus its 200-day average and sits at 30% of its 52-week range (₹62–₹116).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,402% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 4 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Arihant Capital Markets Ltd trades at 1.9× P/BV, mid-range by its own standards (55th percentile). Its long-run median P/BV is 1.8×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 1.9× is mid-range by its own standards (55th percentile), against a long-run median of 1.8× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 8% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved −21.4% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +17.8%/yr price move, ~+23.4%/yr came from book-value growth and ~−5.6 pp from the multiple (compressing); over 10y, of the +26.1%/yr price move, ~+18.3%/yr came from book-value growth and ~+7.8 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Arihant Capital Markets Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −47.5% at the trough to −26.4% off a 1-quarter-old trough. The read is built from 8 quarters across 3 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −16.6% | +14.3% | +12.2% | +13.9% |
| Profit | −47.5% | +2.2% | −2.4% | +13.2% |
| EPS | −49.1% | +0.8% | −2.9% | +13.3% |
| Share price | −21.4% | +17.6% | +17.8% | +26.1% |
4-Factor Sector Score
28.9/100 — rank 14 of 16 in Finance - Capital Markets - Brokers · 80% evidence confidence
Arihant Capital Markets Ltd scores 28.9 out of 100 against the 16 companies it is compared with in Finance - Capital Markets - Brokers, ranking 14. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 6.7 + 11.7 + 6.5 + 4 = 28.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
Arihant Capital Markets Ltd reported ₹78.0 Cr of income in the Jun 26 quarter, +52.9% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 13.9% a year. The last full year, FY26, came in at ₹206 Cr. The last four reported quarters add to ₹233 Cr.
FY26 revenue came in at ₹206 Cr (−16.6% on the year), capping 10 years at 13.9% compound. The latest quarter (Jun 26) printed ₹78.0 Cr, +52.9% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +7.1% growth against the decade's 13.9% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +3.6% over the last 4 quarters against −6.4%/yr over the last 8 — accelerating; TTM profit −26.4% vs −29.7%/yr — accelerating.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
Arihant Capital Markets Ltd's net margin is 26.9% in the Jun 26 quarter, +1.4 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 8.7% to 30.2%. The current quarter sits inside that band.
The latest quarter's net margin is 26.9%, +1.4 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 8.7%–30.2%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Arihant Capital Markets Ltd earned ₹21.0 Cr of net profit in the Jun 26 quarter, +61.5% year on year. Full-year FY26 profit was ₹31.0 Cr. The 10-year compound rate is 13.2%. That is 26.9% of the quarter's revenue. The same quarter a year earlier earned ₹13.0 Cr.
Jun 26 profit was ₹21.0 Cr, +61.5% year on year. On the full year, FY26 printed ₹31.0 Cr (−47.5%), and the 10-year compound rate is 13.2%.
Why profit moved: revenue contributed +52.9% and the margin +1.4 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit −33.0% vs revenue +7.1%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Arihant Capital Markets Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Arihant Capital Markets Ltd's revenue grew −16.6% in FY26 to ₹206 Cr, so the book is flat. The latest quarter ran +52.9% year on year. The net margin on that income is 26.9%, +1.4 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY26 revenue was ₹206 Cr, −16.6% on the year, and the latest quarter ran +52.9% year on year. The net margin on that revenue is 26.9% this quarter (+1.4 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers usually rate a lender: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys.
A clean annual return-on-equity ladder is not held for Arihant Capital Markets Ltd. For an insurer especially the standard bank ratios are not the right lens, so this page does not force them onto the filings rather than estimating a series it cannot support. The revenue, margin and ownership sections above and below are the reads this page stands behind.
We do not hold a clean annual return-on-equity series for Arihant Capital Markets Ltd — for an insurer especially, the standard bank ratios are not the right lens, so this page does not force them. The revenue, margin and ownership sections above and below are the reads we stand behind.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 2.1 points of Arihant Capital Markets Ltd over 8 quarters, the biggest move on the register. That takes promoters to 67.7% of the company. Foreign institutions moved −0.7 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −2.1 points over 8 quarters to 67.7%; Foreign institutions: −0.7 points over 8 quarters to 0.0%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.
🚨 Why the register moved: promoters drove it (−2.1 points), alongside foreign institutions (−0.7 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Arihant Capital Markets Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Indo Thai Securities LtdINDOTHAI | 76.4/100Favorable setup76% evidence | ASLEEP | 32.5/35 Income 100% · PAT 100% 86% evidence | 19.4/25 ROA 17.6% · ROE 28.6% · GNPA — 72% evidence | 12.9/20 P/BV 4.11× · P/BV÷ROE 0.14 70% evidence | 11.6/20 RS sector 27.7% · RS bench -24.3% · 1Y 13.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 32.5 + 19.4 + 12.9 + 11.6 = 76.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Paisalo Digital LtdPAISALO | 66.2/100Favorable setup96% evidence | LEADER | 22.6/35 Income 22.3% · PAT 19.1% 88% evidence | 18.9/25 ROA 3.8% · ROE 14.3% · GNPA 0.7% 100% evidence | 4.7/20 P/BV 3.61× · P/BV÷ROE 0.25 100% evidence | 20.0/20 RS sector 50.8% · RS bench 65.2% · 1Y 118.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.6 + 18.9 + 4.7 + 20 = 66.2 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 3Monarch Networth Capital LtdMONARCH | 61.9/100Mixed-positive evidence78% evidence | TURNING | 19.5/35 Income 13.8% · PAT 20.7% 75% evidence | 19.6/25 ROA 11.5% · ROE 20.5% · GNPA — 72% evidence | 13.2/20 P/BV 3.17× · P/BV÷ROE 0.15 100% evidence | 9.6/20 RS sector -14.3% · RS bench 23.2% · 1Y 6.5%10 of 11 weeks ahead 70% evidence |
| Exact sum: 19.5 + 19.6 + 13.2 + 9.6 = 61.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Share India Securities LtdSHAREINDIA | 58.7/100Mixed-positive evidence76% evidence | TURNING | 18.0/35 Income 14.7% · PAT 17.8% 86% evidence | 15.7/25 ROA 7.1% · ROE 13% · GNPA — 72% evidence | 15.5/20 P/BV 1.48× · P/BV÷ROE 0.11 70% evidence | 9.5/20 RS sector -13.8% · RS bench 15.5% · 1Y 3.8%4 of 11 weeks ahead 70% evidence |
| Exact sum: 18 + 15.7 + 15.5 + 9.5 = 58.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Choice International LtdCHOICEIN | 56.6/100Mixed-positive evidence61% evidence | TURNING | 24.1/35 Income 23% · PAT 46% 45% evidence | 17.8/25 ROA 7.7% · ROE 16.1% · GNPA — 68% evidence | 3.6/20 P/BV 10.97× · P/BV÷ROE 0.68 70% evidence | 11.1/20 RS sector -3.1% · RS bench 7.2% · 1Y 9.5%4 of 10 weeks ahead 70% evidence |
| Exact sum: 24.1 + 17.8 + 3.6 + 11.1 = 56.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 6Anand Rathi Share & Stock Brokers LtdARSSBL | 55.5/100Mixed-positive evidence62% evidence | ASLEEP | 21.0/35 Income 16.9% · PAT 35.4% 86% evidence | 13.3/25 ROA 1.8% · ROE 14% · GNPA — 72% evidence | 11.2/20 P/BV 2.38× · P/BV÷ROE 0.17 70% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 10 weeks ahead 0% evidence |
| Exact sum: 21 + 13.3 + 11.2 + 10 = 55.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Angel One LtdANGELONE | 48.4/100Mixed-negative evidence88% evidence | FADING | 14.1/35 Income 9.1% · PAT 3.9% 86% evidence | 16.3/25 ROA 3.8% · ROE 15.6% · GNPA — 72% evidence | 7.9/20 P/BV 4.43× · P/BV÷ROE 0.28 100% evidence | 10.1/20 RS sector -2.1% · RS bench 8.1% · 1Y 9.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 14.1 + 16.3 + 7.9 + 10.1 = 48.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8SMC Global Securities LtdSMCGLOBAL | 47.5/100Mixed-negative evidence80% evidence | TURNING | 13.0/35 Income 12.3% · PAT -11.3% 81% evidence | 11.5/25 ROA 1.8% · ROE 8.1% · GNPA — 68% evidence | 12.2/20 P/BV 1.3× · P/BV÷ROE 0.16 100% evidence | 10.8/20 RS sector -4.4% · RS bench 11.9% · 1Y 10%5 of 10 weeks ahead 70% evidence |
| Exact sum: 13 + 11.5 + 12.2 + 10.8 = 47.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9IIFL Capital Services LtdIIFLCAPS | 46.7/100Mixed-negative evidence67% evidence | LEADER | 11.9/35 Income 2.1% · PAT -19% 52% evidence | 15.2/25 ROA — · ROE 20.2% · GNPA — 34% evidence | 9.4/20 P/BV 3.43× · P/BV÷ROE 0.17 100% evidence | 10.2/20 RS sector -6.4% · RS bench 3.8% · 1Y 10.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 11.9 + 15.2 + 9.4 + 10.2 = 46.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Meghna Infracon Infrastructure Ltd538668 | 46.2/100Thin evidence · provisional58% evidence | FADING | 14.8/35 Income 15.8% · PAT -42.8% 45% evidence | 15.8/25 ROA — · ROE 21.9% · GNPA — 34% evidence | 3.0/20 P/BV 58.02× · P/BV÷ROE 2.65 70% evidence | 12.6/20 RS sector 5.6% · RS bench 16.8% · 1Y 26.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 15.8 + 3 + 12.6 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Summit Securities LtdSUMMITSEC | 41.4/100Mixed-negative evidence67% evidence | ASLEEP | 23.5/35 Income 30.2% · PAT 54.4% 45% evidence | 6.2/25 ROA 1.1% · ROE 1.1% · GNPA — 68% evidence | 8.6/20 P/BV 0.19× · P/BV÷ROE 0.17 70% evidence | 3.1/20 RS sector -27.3% · RS bench -18.7% · 1Y -27.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.5 + 6.2 + 8.6 + 3.1 = 41.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -27.3% and the one-year return is -27.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Geojit Financial Services LtdGEOJITFSL | 34.7/100Adverse evidence61% evidence | TURNING | 9.0/35 Income -5.5% · PAT -52.3% 52% evidence | 10.8/25 ROA — · ROE 7.3% · GNPA — 34% evidence | 7.4/20 P/BV 1.78× · P/BV÷ROE 0.24 100% evidence | 7.5/20 RS sector -16.6% · RS bench 4.5% · 1Y 2.4%10 of 10 weeks ahead 70% evidence |
| Exact sum: 9 + 10.8 + 7.4 + 7.5 = 34.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 135paisa Capital Ltd5PAISA | 30.5/100Adverse evidence80% evidence | TURNING | 8.6/35 Income -1.8% · PAT -26.7% 81% evidence | 11.2/25 ROA 2.3% · ROE 7% · GNPA — 68% evidence | 4.5/20 P/BV 2.53× · P/BV÷ROE 0.36 100% evidence | 6.2/20 RS sector -18.5% · RS bench 2.7% · 1Y -10%3 of 10 weeks ahead 70% evidence |
| Exact sum: 8.6 + 11.2 + 4.5 + 6.2 = 30.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Arihant Capital Markets Ltdthis pageARIHANTCAP | 28.9/100Adverse evidence80% evidence | TURNING | 6.7/35 Income 3.6% · PAT -26.4% 81% evidence | 11.7/25 ROA 2.8% · ROE 7.7% · GNPA — 68% evidence | 6.5/20 P/BV 1.95× · P/BV÷ROE 0.25 100% evidence | 4.0/20 RS sector -20.8% · RS bench -9.7% · 1Y -22.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 6.7 + 11.7 + 6.5 + 4 = 28.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Emkay Global Financial Services LtdEMKAY | 25.0/100Adverse evidence80% evidence | TURNING | 9.9/35 Income 21.3% · PAT -59.1% 81% evidence | 5.9/25 ROA 0.9% · ROE 4.5% · GNPA — 68% evidence | 2.8/20 P/BV 1.67× · P/BV÷ROE 0.37 100% evidence | 6.4/20 RS sector -11.5% · RS bench -7.4% · 1Y -3.5%5 of 10 weeks ahead 70% evidence |
| Exact sum: 9.9 + 5.9 + 2.8 + 6.4 = 25 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Billionbrains Garage Ventures LtdGROWW | 54.8/100Thin evidence · provisional41% evidence | ASLEEP | 24.7/35 Income 37.7% · PAT 30.9% 52% evidence | 16.3/25 ROA — · ROE 28.8% · GNPA — 34% evidence | 3.8/20 P/BV 12.6× · P/BV÷ROE 0.44 70% evidence | 10.0/20 RS sector — · RS bench — · 1Y —8 of 12 weeks ahead 0% evidence |
| Exact sum: 24.7 + 16.3 + 3.8 + 10 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Arihant Capital Markets Ltd's share price today?
Arihant Capital Markets Ltd trades at ₹78.3, −21.4% over the past year. The company is valued at ₹859 Cr. The stock sits at 30% of its 52-week range of ₹62–₹116, +0.4% versus its 200-day average. On the tape, the price is in a downtrend, 28 weeks in. — as of 31 July 2026.
What were Arihant Capital Markets Ltd's latest quarterly results?
Arihant Capital Markets Ltd reported total income of ₹78.0 Cr and net profit of ₹21.0 Cr for the Jun 26 quarter. Income rose 52.9% and profit rose 61.5% year on year. Earnings per share were ₹1.96. The net margin was 26.9%, 1.4 pp higher than a year earlier. — as of 31 July 2026.
What is Arihant Capital Markets Ltd's revenue?
Arihant Capital Markets Ltd reported revenue of ₹78.0 Cr in the Jun 26 quarter, +52.9% year on year. For the full FY26 fiscal year, revenue was ₹206 Cr (−16.6%). Over the last 10 years revenue compounded at 13.9% a year. — as of 31 July 2026.
What is Arihant Capital Markets Ltd's profit?
Arihant Capital Markets Ltd earned ₹21.0 Cr of net profit in the Jun 26 quarter, +61.5% year on year. Full-year FY26 profit was ₹31.0 Cr. The net margin ran 26.9% in the latest quarter. — as of 31 July 2026.
What is Arihant Capital Markets Ltd's market cap?
Arihant Capital Markets Ltd's market capitalisation is ₹859 Cr at a share price of ₹78.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Arihant Capital Markets Ltd's P/BV ratio?
Arihant Capital Markets Ltd trades at a P/BV of 1.9×, at the 55th percentile of its own 10-year range, against a long-run median of 1.8×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Arihant Capital Markets Ltd pay a dividend?
Yes — Arihant Capital Markets Ltd's dividend payout was 17% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Arihant Capital Markets Ltd overvalued?
On its own history, Arihant Capital Markets Ltd looks mid-range against its own history: its P/BV of 1.9× sits at the 55th percentile of its 10-year range (long-run median 1.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Arihant Capital Markets Ltd growing?
Yes — Arihant Capital Markets Ltd is growing: latest-quarter revenue +52.9% year on year, profit +61.5%, and the the net margin +1.4 pp at 26.9%. The 10-year compound rates are 13.9% (revenue) and 13.2% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Arihant Capital Markets Ltd performing?
Arihant Capital Markets Ltd is in a downtrend, 28 weeks in. Its latest quarter's income rose 52.9% and profit rose 61.5% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Arihant Capital Markets Ltd in?
Turning around — profit growth swung from −47.5% at the trough to −26.4% off a 1-quarter-old trough. The read comes from the last 12 quarters of growth (revenue growth +3.6% latest, profit growth −26.4% latest, eps growth −26.3% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Arihant Capital Markets Ltd in an uptrend?
No — the price is in a downtrend (week 28 of stage 4), trading +0.4% versus its 200-day average and at 30% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Arihant Capital Markets Ltd beating the market?
On recent form, yes — Arihant Capital Markets Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 4 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,402% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Arihant Capital Markets Ltd's share price go up?
This page publishes no price forecast for Arihant Capital Markets Ltd. What it measures instead: the share price is ₹78.3, the price is in a downtrend 28 weeks in. Its P/BV of 1.9× sits at the 55th percentile of its own 10-year range. — as of 31 July 2026.
Who owns Arihant Capital Markets Ltd?
Promoters hold 67.7% of Arihant Capital Markets Ltd, foreign institutions 0.0%, domestic institutions 0.0% and the public 32.2% (latest quarter). The biggest move on the register over the last two years: Promoters cut 2.1 points over 8 quarters. — as of 31 July 2026.
Is Arihant Capital Markets Ltd's loan book healthy?
We do not hold quarterly loan-book quality numbers for Arihant Capital Markets Ltd, so this page says that plainly. The cleanest available reads are revenue growth (−16.6% in FY26) and the net margin on it (26.9%) — as of 31 July 2026.
Where is Arihant Capital Markets Ltd in its business cycle?
Arihant Capital Markets Ltd's FY26 net margin was 15.0%, against a 13-year band of 8.7%–30.2%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 26.9%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Arihant Capital Markets Ltd story?
The sharpest disagreement: the price moved −21.4% in a year while annual EPS moved −49.1% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Arihant Capital Markets Ltd a stock worth studying right now?
This is not investment advice. The machine read: Arihant Capital Markets Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.